These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 13843781)

  • 1. Study of a vaccine strain of Mycobaterium tuberculosis.
    WEISSFEILER J; KARASSOVA V
    Acta Microbiol Acad Sci Hung; 1960; 7():77-86. PubMed ID: 13843781
    [No Abstract]   [Full Text] [Related]  

  • 2. Serological studies of mycobacteria by means of diffusion-in-gel techniques. VI. Physical, chemical and immunological characteristics of precipitinogenic factors in an antigenic preparation from a culture filtrate of a virulent strain of M. tuberculosis.
    LIND A
    Int Arch Allergy Appl Immunol; 1961; 19():1-45. PubMed ID: 13762235
    [No Abstract]   [Full Text] [Related]  

  • 3. Differential Mycobacterium bovis BCG vaccine-derived efficacy in C3Heb/FeJ and C3H/HeOuJ mice exposed to a clinical strain of Mycobacterium tuberculosis.
    Henao-Tamayo M; Obregón-Henao A; Creissen E; Shanley C; Orme I; Ordway DJ
    Clin Vaccine Immunol; 2015 Jan; 22(1):91-8. PubMed ID: 25392011
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protection by live Mycobacterium habana vaccine against Mycobacterium tuberculosis H37Rv challenge in mice.
    Prem Raj P; Srivastava S; Jain SK; Srivastava BS; Srivastava R
    Indian J Med Res; 2003 Apr; 117():139-45. PubMed ID: 14604301
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protective Vaccine Efficacy of the Complete Form of PPE39 Protein from Mycobacterium tuberculosis Beijing/K Strain in Mice.
    Kim A; Hur YG; Gu S; Cho SN
    Clin Vaccine Immunol; 2017 Nov; 24(11):. PubMed ID: 28877927
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Proceedings: Immunology of Mycobacterium and its infection].
    Kekkaku; 1975 Mar; 50(3):49-57. PubMed ID: 805315
    [No Abstract]   [Full Text] [Related]  

  • 7. Self-inoculation with Mycobacterium tuberculosis Weiszfeiler W-115.
    Sula L
    Acta Microbiol Acad Sci Hung; 1979; 26(1):85-90. PubMed ID: 113990
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Immunology of tuberculosis: impact on the development of novel vaccines].
    Ulrichs T; Kaufmann SH
    Internist (Berl); 2003 Nov; 44(11):1374-84. PubMed ID: 14689073
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tuberculosis vaccine research: the impact of immunology.
    Barker LF; Brennan MJ; Rosenstein PK; Sadoff JC
    Curr Opin Immunol; 2009 Jun; 21(3):331-8. PubMed ID: 19505813
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The antigens produced in vitro by Mycobacterium tuberculosis, with some observations on the frequency of anaphylactic sensitization during the course of experimental tuberculosis.
    PLATT H
    Br J Exp Pathol; 1954 Oct; 35(5):439-46. PubMed ID: 13208933
    [No Abstract]   [Full Text] [Related]  

  • 11. [Immunology of tuberculosis].
    Estrada-Parra S; García Procel E
    Salud Publica Mex; 1982; 24(3):269-78. PubMed ID: 6815811
    [No Abstract]   [Full Text] [Related]  

  • 12. Mycobacterium tuberculosis sigE mutant ST28 used as a vaccine induces protective immunity in the guinea pig model.
    Troudt J; Creissen E; Izzo L; Bielefeldt-Ohmann H; Casonato S; Manganelli R; Izzo AA
    Tuberculosis (Edinb); 2017 Sep; 106():99-105. PubMed ID: 28802412
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Experimental study of BCG and urea-treated tubercle bacilli].
    AUFDERMAUR M; BRODHAGE H
    Schweiz Z Pathol Bakteriol; 1955; 18(6):1237-43. PubMed ID: 13337295
    [No Abstract]   [Full Text] [Related]  

  • 14. [Experimental tuberculosis and the existence of 3 different antibodies: antipolysaccharide, antiprotein and antiphosphatide].
    TAKAHASHI Y; ONODERA T
    C R Seances Soc Biol Fil; 1960; 154():887-9. PubMed ID: 13774907
    [No Abstract]   [Full Text] [Related]  

  • 15. The immunology of tuberculosis.
    Collins FM
    Am Rev Respir Dis; 1982 Mar; 125(3 Pt 2):42-9. PubMed ID: 6803632
    [No Abstract]   [Full Text] [Related]  

  • 16. The immunising efficiency of the avirulent strain M. tuberculosis Weiszfeiler no. 115/9.
    Sulová J; Spurná M
    J Hyg Epidemiol Microbiol Immunol; 1975; 19(4):498-503. PubMed ID: 812910
    [No Abstract]   [Full Text] [Related]  

  • 17. Evaluation of Immunogenicity and Protective Efficacy Elicited by Mycobacterium bovis BCG Overexpressing Ag85A Protein against Mycobacterium tuberculosis Aerosol Infection.
    Xu ZZ; Chen X; Hu T; Meng C; Wang XB; Rao Y; Zhang XM; Yin YL; Pan ZM; Jiao XA
    Front Cell Infect Microbiol; 2016; 6():3. PubMed ID: 26858942
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Progress in tuberculosis vaccine development.
    Baumann S; Nasser Eddine A; Kaufmann SH
    Curr Opin Immunol; 2006 Aug; 18(4):438-48. PubMed ID: 16777396
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mycobacterium tuberculosis.
    Venketaraman V; Kaushal D; Saviola B
    J Immunol Res; 2015; 2015():857598. PubMed ID: 26345333
    [No Abstract]   [Full Text] [Related]  

  • 20. Fact and fiction in tuberculosis vaccine research: 10 years later.
    Kaufmann SH
    Lancet Infect Dis; 2011 Aug; 11(8):633-40. PubMed ID: 21798463
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.